Schuylkill Financial LLC Takes Position in iShares U.S. Pharmaceuticals ETF $IHE

Schuylkill Financial LLC bought a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 10,018 shares of the company’s stock, valued at approximately $992,000. Schuylkill Financial LLC owned about 0.06% of iShares U.S. Pharmaceuticals ETF at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of IHE. Foundations Investment Advisors LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $54,513,000. BNP Paribas Financial Markets purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the second quarter worth about $13,108,000. JPMorgan Chase & Co. increased its position in shares of iShares U.S. Pharmaceuticals ETF by 89.4% during the fourth quarter. JPMorgan Chase & Co. now owns 212,805 shares of the company’s stock worth $18,052,000 after purchasing an additional 100,426 shares in the last quarter. Cetera Investment Advisers increased its position in shares of iShares U.S. Pharmaceuticals ETF by 675.4% during the first quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock worth $9,489,000 after purchasing an additional 95,353 shares in the last quarter. Finally, Royal Bank of Canada lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 51.9% in the 4th quarter. Royal Bank of Canada now owns 156,973 shares of the company’s stock valued at $13,315,000 after purchasing an additional 53,661 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

iShares U.S. Pharmaceuticals ETF stock opened at $104.68 on Friday. The company has a market capitalization of $1.68 billion, a P/E ratio of 17.75 and a beta of 0.49. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $69.02 and a fifty-two week high of $108.66. The stock has a 50-day simple moving average of $102.63 and a 200-day simple moving average of $93.91.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.